The article presents the synthesis of 2-arylimino-4-methyl-2,3-dihydro-1,3-thiazoles via Hantzsch reaction of thioureas and 3-chloropentane-2,4-dione or ethyl 2-chloro-3-oxobutanoate. The structure of synthesized compounds was confirmed by LCMS, 1H, and 13C NMR spectra. Cardioprotective activity of synthesized thiazole derivatives were studied in vitro on the isolated rings of the thoracic aorta of laboratory rats. Based on pharmacological studies, the tested compounds possessed a moderate to high cardioprotective effect. A prospective 1-[2-(4-methoxyphenylimino)-4-methyl-3-(4-methylpiperazine-1-yl)-2,3-dihydro-1,3-thiazole-5-yl] ethan-1-one hydrochloride 4c was identified. The mentioned compound has delayed the development of constrictor responses of isolated rings of the thoracic rat aorta and exceeds the activity of L-carnitine by 18.2% and meldonium by 12.9%. The compound 4c may be proposed as a potential cardioprotective agent for in-depth pharmacological studies.
Background/Objectives: The Canadian goldenrod (Solidago canadensis L.) is one of the most widespread species of the genus Solidago from the Asteraceae family. It has a rich composition of biologically active compounds and is traditionally used to address kidney, urinary tract, and liver diseases. Previously, it was proven that the S. canadensis extract obtained with a 40% ethanol solution had the most promising anti-inflammatory and hepatoprotective activity. Therefore, this extract was selected for the further formulation of amino acid preparations and 3D-printed dosage forms. The aims of the present study were to investigate the chemical composition, toxicity, and antimicrobial, anti-inflammatory, and hepatoprotective activity of S. canadensis dry extract, its amino acid preparations, and 3D-printed dosage forms. Results: A total of 18 phenolic compounds and 14 amino acids were determined in the extracts. The S. canadensis herb extracts were verified to be practically non-toxic preparations (toxicity class V, LD₅₀ > 5000 mg/kg). They also showed moderate antimicrobial activity against Staphylococcus aureus, Enterococcus faecalis, and β-hemolytic Streptococcus pyogenes. The most pronounced hepatoprotective activity was observed with S. canadensis herb extract and its amino acid preparations with phenylalanine, alanine, and lysine at a dose of 25 mg/kg body weight. The most pronounced anti-inflammatory activity was found with S. canadensis herb extract and its preparation with arginine. According to the calculated docking score array and the analysis of binding modes in the active sites of COX-1 and COX-2, the flavonoid fraction and caffeic acid in the S. canadensis extracts presented moderate inhibitory activity. Conclusions: The development of innovative 3D-printed oral dosage forms represents a promising strategy to formulate dietary supplements or pharmaceutical preparations for these herbal extracts.
1 January 2019 in Research Journal of Pharmacy and Technology
Leaf extracts of several South African tree species with activity against Cryptococcus neoformans were evaluated for activity against Aspergillus fumigatus the causal agent of aspergillosis, an economically important disease in birds. The Loxostylis alata acetone leaf extract had a good inhibitory activity with an MIC of 50 ug/mL [1]. The main antifungal agent present in the extract, lupeol had a lower activity than the crude extract against A. fumigatus (MIC of 92 ug/mL) indicating strong synergistic effects. The toxicity and antifungal activity of the crude L. alata acetone leaf extract was evaluated in broiler chicks. Experimental aspergillosis was induced by intraperitoneal infection with A. fumigatus. Because the extract had some toxicity at a dose of 300mg/kg, lower doses were used. Antifungal activity was assessed by comparing degree and severity of clinical signs, lesion scores, fungal re-isolation and a series of biochemical and haematological indices observed between chicks treated with the extract and not-treated chicks. The extract at the doses of 100 and 200mg/kg significantly reduced the lesions induced by the aspergillosis, as well as the number of fungal colonies isolated from infected chick lungs (p ≤0.05) in a dose dependent manner. The crude extract proved to be as effective as the positive control ketoconazole dosed at 60mg/kg, the highest non-toxic dose. The results indicate that a crude extract of L. alata leaves has potential as an antifungal agent to protect poultry against avian aspergillosis. Acknowledgements: The National Research Foundation of South Africa provided funding. References: 1. Suleiman MM. et al. (2010) S. Afr, Jl Botany 76:64–71.
Background/Objectives: Canadian goldenrod (Solidago canadensis L.) is one of the most widespread species of genus Solidago from Asteraceae family. It has a rich composition of biologically active compounds and traditionally is used to address kidney, urinary tract, and liver diseases. Previously, it was proven that the S. canadensis extract obtained with 40% ethanol solution had the most promising anti-inflammatory and hepatoprotective activity. Therefore, this extract was selected for the further formulation of amino acids preparations and 3D-printed dosage forms. The aims of the present study were to investigate the chemical composition, toxicity, and the antimicrobial, anti-inflammatory and hepatoprotective activity of S. canadensis dry extract, its amino acids preparations and 3D-printed dosage forms. Results: A total of 18 phenolic compounds and 14 amino acids were determined in the extracts. The S. canadensis herb extracts were verified to be practically non-toxic preparations (toxicity class V, LD₅₀ > 5000 mg/kg). They showed also a moderate antimicrobial activity against Staphylococcus aureus, Enterococcus faecalis and β-hemolytic Streptococcus pyogenes. The most pronounced hepatoprotective activity was observed with S. canadensis herb extract and its amino acids preparations with phenylalanine, alanine and lysine at a dose of 25 mg/kg body weight. The most pronounced anti-inflammatory activity was found with S. canadensis herb extract and its preparation with arginine. According to the calculated docking score array and the analysis of binding modes in the active sites of COX-1 and COX-2, the flavonoid fraction and caffeic acid in the S. canadensis extracts presented a moderate inhibitory activity. Conclusions: The development of innovative 3D-printed oral dosage forms represents a promising strategy to formulate the dietary supplements or pharmaceutical preparations for these herbal extracts.
31 August 2020 in ScienceRise: Pharmaceutical Science